MARKET

ALXO

ALXO

Alx Oncology Holdings Inc
NASDAQ
2.365
+0.315
+15.37%
Opening 14:35 02/09 EST
OPEN
2.080
PREV CLOSE
2.050
HIGH
2.366
LOW
1.981
VOLUME
665.32K
TURNOVER
--
52 WEEK HIGH
2.410
52 WEEK LOW
0.4040
MARKET CAP
310.28M
P/E (TTM)
-1.1739
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ALXO last week (0202-0206)?
Weekly Report · 11h ago
ALX Oncology Is Maintained at Overweight by Piper Sandler
Dow Jones · 4d ago
Piper Sandler Maintains Overweight on ALX Oncology Holdings, Raises Price Target to $4
Benzinga · 4d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 4d ago
ALX Oncology price target raised to $4 from $3 at Piper Sandler
TipRanks · 4d ago
Top Insider Quietly Makes a Massive Bet on This Biotech Stock
TipRanks · 4d ago
ALX Oncology jumps on venture capital fund share purchase
Seeking Alpha · 4d ago
Director and 10% Owner Corey S. Goodman Reports Acquisition of ALX Oncology Holdings Inc. Common Shares
Reuters · 4d ago
More
About ALXO
ALX Oncology Holdings Inc. is a clinical-stage biotechnology company advancing a pipeline of therapies designed to treat cancer and extend patients’ lives. The Company's lead product candidate, evorpacept, is a CD47 blocking therapeutic that combines a high-affinity CD47 binding domain with an inactivated, proprietary Fc domain. It is engaged in focusing on combining evorpacept with anti-cancer antibodies, antibody drug conjugate (ADCs), and PD-1/PD-L1 immune checkpoint inhibitors. Evorpacept is being evaluated across multiple ongoing clinical trials in a range of cancer indications. Its second product candidate is ALX2004, an epidermal growth factor receptor (EGFR)-targeted ADC. ALX2004 comprises an affinity-tuned EGFR antibody backbone engineered for optimal activity as an ADC, a proprietary topoisomerase I inhibitor payload with enhanced bystander effect, and a linker with enhanced stability.

Webull offers ALX Oncology Holdings Inc stock information, including NASDAQ: ALXO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALXO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALXO stock methods without spending real money on the virtual paper trading platform.